Suvarna Sangale*
Inhibiting ergosterol synthesis, a crucial component of fungal cell membranes, results in membrane disruption and fungal cell death. Fluconazole is a broad-spectrum antifungal medication that belongs to the triazole class and is commonly used to treat superficial fungal infections, including dermatophytosis, tinea infections, and candidiasis. The fungal cytochrome P450-dependent enzyme lanosterol 14-α-demethylase, which is necessary for the synthesis of ergosterol, a key structural element of the fungal cell membrane, is selectively inhibited by fluconazole. Blocking this enzyme prevents lanosterol from being converted to ergosterol, which results in an excess of ergosterol and the buildup of toxic, aberrant sterols inside the fungal cell. The cell membrane thus becomes weak and porous, making it difficult to sustain regular processes like growth and permeability control. In the end, this disruption results in the organism's death and prevention of fungal cell reproduction. Crucially, fluconazole is a safe and efficient antifungal drug due to its excellent selectivity for fungal enzymes and negligible impact on human sterol production. Worldwide, the prevalence of fungal infections of the skin, hair, and nails has increased. A fungal infection can spread quickly and seriously. Numerous fungal species, particularly Candida albicans, are the primary cause of fungal infections. These species thrive and spread on the skin's surface, causing symptoms such skin thickening, reddening, and itching. Transdermal medication delivery systems can treat important problems like vaginal infections and skin infections like onchocytosis. Most often, topical semisolid dose forms are used to treat fungal infections on the skin in order to prevent the GIT irritations, either systemic or otherwise. Targeting the infection site, reducing systemic side effects, and achieving high patient compliance are just a few advantages of topical treatment for fungal infections. Various topical antifungal compounds have been used to treat a variety of skin infections, but they are unable to deeply penetrate the stratum corneum layer and instead remain there, making this system a complete failure. The skin serves as both a major target and a barrier for the delivery of topical drugs. An inventive method for the topical administration of fluconazole is the use of ethosomal solutions filled with the drug. Phospholipids, ethanol, and water make up ethersomes, which are vesicular transporters. These formulations are intended to improve the drug's ability to pass through the skin, delivering a precise and regulated release of the active ingredient right at the infection site.
Skin:
The primary components of skin are skin layers, which are made up of small wrinkles, hairs, and lipids on the skin's outermost surface. Additional components of skin include skin layers. The optical behaviors of these components vary greatly depending on their structural makeup.
Skin layers:
The most versatile and broad route for topical and systemic drug administration is the skin. When applied topically, the stratum corneum, the skin's outermost layer, limits the bioavailability of medications by acting as the skin's strongest barrier to drug penetration.
10.5281/zenodo.18851378